Sara Kalkhoran1, Nicole A Appelle1, Anna M Napoles1, Ricardo F Munoz2, Paula J Lum3, Nicholas Alvarado1, Steven E Gregorich1, Jason M Satterfield4. 1. Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. 2. Palo Alto University, Palo Alto, CA, USA; San Francisco General Hospital, Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA. 3. Division of HIV/AIDS, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. 4. Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. Electronic address: Jason.Satterfield@ucsf.edu.
Abstract
BACKGROUND: The 5As for smoking cessation is an evidence-based intervention to aid providers in counseling patients to quit smoking. While most providers "ask" patients about their tobacco use patterns and "advise" them to quit, fewer patients report being "assessed" for their interest in quitting, and even fewer report subsequent "assistance" in a quit attempt and having follow-up "arranged". PURPOSE: This article describes the design of an implementation study testing a computer tablet intervention to improve provider adherence to the 5As for smoking cessation. Findings will contribute to the existing literature on technology acceptance for addressing addictive behaviors, and how digital tools may facilitate the broader implementation of evidence-based behavioral counseling practices without adversely affecting clinical flow or patient care. METHODS: This project develops and tests a computer-facilitated 5As (CF-5As) model that administers the 5As intervention to patients with a computer tablet, then prompts providers to reinforce next steps. During the development phase, 5As' content will be programmed onto computer tablets, alpha and beta-testing of the service delivery model will be done, and pre-intervention interview and questionnaire data will be collected from patients, providers, and clinic staff about 5As fidelity and technology adoption. During the program evaluation phase, a randomized controlled trial comparing a group who receives the CF-5As intervention to one that does not will be conducted to assess 5As fidelity. Using the technology acceptance model, a mixed methods study of contextual and human factors influencing both 5As and technology adoption will also be conducted. CONCLUSIONS: Technology is increasingly being used in clinical settings. A technological tool that connects patients, providers, and clinic staff to facilitate the promotion of behavioral interventions such as smoking cessation may provide an innovative platform through which to efficiently and effectively implement evidence-based practices.
RCT Entities:
BACKGROUND: The 5As for smoking cessation is an evidence-based intervention to aid providers in counseling patients to quit smoking. While most providers "ask" patients about their tobacco use patterns and "advise" them to quit, fewer patients report being "assessed" for their interest in quitting, and even fewer report subsequent "assistance" in a quit attempt and having follow-up "arranged". PURPOSE: This article describes the design of an implementation study testing a computer tablet intervention to improve provider adherence to the 5As for smoking cessation. Findings will contribute to the existing literature on technology acceptance for addressing addictive behaviors, and how digital tools may facilitate the broader implementation of evidence-based behavioral counseling practices without adversely affecting clinical flow or patient care. METHODS: This project develops and tests a computer-facilitated 5As (CF-5As) model that administers the 5As intervention to patients with a computer tablet, then prompts providers to reinforce next steps. During the development phase, 5As' content will be programmed onto computer tablets, alpha and beta-testing of the service delivery model will be done, and pre-intervention interview and questionnaire data will be collected from patients, providers, and clinic staff about 5As fidelity and technology adoption. During the program evaluation phase, a randomized controlled trial comparing a group who receives the CF-5As intervention to one that does not will be conducted to assess 5As fidelity. Using the technology acceptance model, a mixed methods study of contextual and human factors influencing both 5As and technology adoption will also be conducted. CONCLUSIONS: Technology is increasingly being used in clinical settings. A technological tool that connects patients, providers, and clinic staff to facilitate the promotion of behavioral interventions such as smoking cessation may provide an innovative platform through which to efficiently and effectively implement evidence-based practices.
Authors: Jessica Clark Newman; Don C Des Jarlais; Charles F Turner; Jay Gribble; Phillip Cooley; Denise Paone Journal: Am J Public Health Date: 2002-02 Impact factor: 9.308
Authors: Robert P Schwartz; Jan Gryczynski; Shannon Gwin Mitchell; Arturo Gonzales; Ana Moseley; Thomas R Peterson; Steven J Ondersma; Kevin E O'Grady Journal: Addiction Date: 2014-03-10 Impact factor: 6.526
Authors: Nathan M Souza; Rolf J Sebaldt; Jean A Mackay; Jeanette C Prorok; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes Journal: Implement Sci Date: 2011-08-03 Impact factor: 7.327
Authors: Ahmed Jamal; Israel T Agaku; Erin O'Connor; Brian A King; John B Kenemer; Linda Neff Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Sara Kalkhoran; Nicholas Alvarado; Maya Vijayaraghavan; Paula J Lum; Patrick Yuan; Jason M Satterfield Journal: J Gen Intern Med Date: 2017-07-14 Impact factor: 5.128
Authors: Jason M Satterfield; Steven E Gregorich; Sara Kalkhoran; Paula J Lum; Jessica Bloome; Nicholas Alvarado; Ricardo F Muñoz; Maya Vijayaraghavan Journal: Am J Prev Med Date: 2018-06-18 Impact factor: 5.043
Authors: Bian Liu; Serena Zhan; Karen M Wilson; Madhu Mazumdar; Lihua Li Journal: Int J Environ Res Public Health Date: 2021-04-26 Impact factor: 4.614
Authors: Maya Vijayaraghavan; Patrick Yuan; Steven Gregorich; Paula Lum; Nicole Appelle; Anna Maria Napoles; Sara Kalkhoran; Jason Satterfield Journal: Prev Med Rep Date: 2017-02-21
Authors: Anna María Nápoles; Nicole Appelle; Sara Kalkhoran; Maya Vijayaraghavan; Nicholas Alvarado; Jason Satterfield Journal: BMC Med Inform Decis Mak Date: 2016-04-19 Impact factor: 2.796